End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
6,013.85 INR | +0.23% | -0.08% | -26.33% |
Sales 2023 | 2,123 M 25.51 M | Sales 2024 * | - | Capitalization | 19.16 B 230 M |
---|---|---|---|---|---|
Net income 2023 | 540 M 6.49 M | Net income 2024 * | - | EV / Sales 2023 | 8,69x |
Net cash position 2023 | 706 M 8.48 M | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 | 35,5x | P/E ratio 2024 * | Employees | 335 | |
Yield 2023 | 0,28% | Yield 2024 * |
-
| Free-Float | 27.73% |
More Fundamentals
* Assessed data
More news
1 day | +0.23% | ||
1 week | -0.08% | ||
Current month | +0.23% | ||
1 month | +1.23% | ||
3 months | -11.08% | ||
6 months | -13.21% | ||
Current year | -26.33% |
1 week
5 950.00
6 150.00

1 month
5 859.00
6 399.95

Current year
5 859.00
8 250.00

1 year
5 859.00
8 700.00

3 years
3 205.00
12 400.00

5 years
1 301.80
12 400.00

10 years
125.00
12 400.00

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 2013 | |
Kirti Shah
DFI | Director of Finance/CFO | - | 2019 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 2005 | |
Director/Board Member | 43 | 2006 | |
Director/Board Member | 73 | 2005 |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 6,013.85 | +0.23% | 1,441 |
23-11-30 | 6,000.20 | -0.07% | 2,210 |
23-11-29 | 6,004.15 | +0.37% | 857 |
23-11-28 | 5,982.30 | -0.61% | 1,486 |
End-of-day quote Bombay Stock Exchange, December 30, 2023
More quotes
Paushak Limited is a pharmaceutical company. It is engaged in the business of manufacturing phosgene-based specialty chemicals and intermediates. It is also involved in manufacturing organic intermediates, such as Isocyanates, Chloroformates and Carbonyl Chlorides. The Company's product Isocyanates include 2-Chloro Ethyl Isocyanate, 2-Phenyl Ethyl Isocyanate, 3-Chlorophenyl Isocyanate, 4-Chloro-3-(trifluoromethyl) Phenl Isocynate, P-Toluenesulfonyl Isocyanate, and Trans-4-Methyl Cyclohexyl Isocyanate. Its Chloroformates products include 2-Ethylhexyl Chloroformate, Allyl Chloroformate, Benzyle Chloroformate, Cetyl Chloroformate, and Ethyl Chloroformate. Its Carbonate/ Carbamate products include Polyquaternium, N-Butyl Propargyl Carbonate, and 3-Iodo 2 propynyl N-butyl Carbonate. Its Chlorides products include 3-Chloropropionyl Cloride, 4-Chloro Butyryl Cloride, and Diphenyl Carbamoyl Cloride. Its other products include Tetrabutyl Urea, Vilsmeier Reagent, and Fenofibric Acid.
Sector
Specialty Chemicals
Calendar
2024-01-25
- Q3 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
1st Jan change | Capi. | |
---|---|---|
-26.33% | 223 M $ | |
+32.18% | 54 861 M $ | |
+6.81% | 43 640 M $ | |
+16.59% | 35 014 M $ | |
-0.72% | 16 700 M $ | |
+2.75% | 15 857 M $ | |
-41.82% | 14 805 M $ | |
+35.82% | 10 248 M $ | |
-3.07% | 8 799 M $ | |
-39.99% | 8 242 M $ |